Not compared to the institutional who are raising this higher. 10% retail max. They all have their scientists looking at the fast track data and clearly many say buy. Lot to work with here on their drug even if it's not 100% viable. 20 bucks with a fail here 75 with a win next month
News 
Market Data 
Discover 
